Hexi Du

512 total citations
25 papers, 334 citations indexed

About

Hexi Du is a scholar working on Urology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Hexi Du has authored 25 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Urology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Hexi Du's work include Urinary Bladder and Prostate Research (12 papers), Hormonal and reproductive studies (5 papers) and Pelvic floor disorders treatments (4 papers). Hexi Du is often cited by papers focused on Urinary Bladder and Prostate Research (12 papers), Hormonal and reproductive studies (5 papers) and Pelvic floor disorders treatments (4 papers). Hexi Du collaborates with scholars based in China and Germany. Hexi Du's co-authors include Chang Yin Liang, Ligang Zhang, Li Zhang, Jing Chen, Xianguo Chen, Zhifeng Yu, Yi Liu, Xiaoliang Hua, Yu Guan and Yang Chen and has published in prestigious journals such as The FASEB Journal, Frontiers in Immunology and Frontiers in Microbiology.

In The Last Decade

Hexi Du

23 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hexi Du China 12 143 87 53 53 44 25 334
Samia Warsame Kuwait 10 192 1.3× 30 0.3× 7 0.1× 80 1.5× 18 0.4× 14 524
Xing Tu China 10 161 1.1× 5 0.1× 37 0.7× 16 0.3× 17 0.4× 16 326
Wei Shan China 9 58 0.4× 33 0.4× 36 0.7× 14 0.3× 23 0.5× 17 301
Brooke E. Shaner United States 7 131 0.9× 35 0.4× 21 0.4× 21 0.4× 10 0.2× 8 260
Moyan Liu China 11 159 1.1× 3 0.0× 41 0.8× 34 0.6× 25 0.6× 23 383
Wiwit Ananda Wahyu Setyaningsih Indonesia 10 98 0.7× 9 0.1× 17 0.3× 16 0.3× 11 0.3× 28 283
Angel Isidro Puerto Rico 10 194 1.4× 3 0.0× 27 0.5× 43 0.8× 20 0.5× 16 408
Yingqian Zhu China 8 145 1.0× 4 0.0× 22 0.4× 19 0.4× 16 0.4× 16 312
Zhong Cao China 7 126 0.9× 4 0.0× 17 0.3× 51 1.0× 18 0.4× 12 322

Countries citing papers authored by Hexi Du

Since Specialization
Citations

This map shows the geographic impact of Hexi Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hexi Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hexi Du more than expected).

Fields of papers citing papers by Hexi Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hexi Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hexi Du. The network helps show where Hexi Du may publish in the future.

Co-authorship network of co-authors of Hexi Du

This figure shows the co-authorship network connecting the top 25 collaborators of Hexi Du. A scholar is included among the top collaborators of Hexi Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hexi Du. Hexi Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Lei, Jia Chen, Hexi Du, et al.. (2024). CXCL10 Promotes Spinal Macrophage Recruitment via the JAK/STAT3 Pathway to Induce Pain in Experimental Autoimmune Prostatitis. Cell Proliferation. 58(4). e13784–e13784. 2 indexed citations
2.
Yu, Zhifeng, Hexi Du, Shan Gao, & Chang Yin Liang. (2024). Eriocalyxin B ameliorated experimental autoimmune prostatitis via modulation of macrophage polarization through gut microbiota-mediated vitamin D3 alteration. Phytomedicine. 135. 156191–156191. 3 indexed citations
3.
Du, Hexi, Xianhong Liu, Weiyi Li, et al.. (2024). Alcohol intake exacerbates experimental autoimmune prostatitis through gut microbiota driving cholesterol biosynthesis-mediated Th17 differentiation. International Immunopharmacology. 139. 112669–112669. 3 indexed citations
5.
Li, Weiyi, Shun Xu, Wenlong Xu, et al.. (2024). Causality investigation among gut microbiota, immune cells, and prostate diseases: a Mendelian randomization study. Frontiers in Microbiology. 15. 1445304–1445304. 3 indexed citations
6.
Liu, Xianhong, et al.. (2023). BLCA prognostic model creation and validation based on immune gene-metabolic gene combination. Discover Oncology. 14(1). 232–232. 1 indexed citations
7.
Guan, Yu, Jialin Meng, Ke Ding, et al.. (2023). The CXCL10/CXCR3 axis regulates Th1 cell differentiation and migration in experimental autoimmune prostatitis through the PI3K/AKT pathway. Andrology. 12(6). 1408–1418. 12 indexed citations
8.
Hua, Xiaoliang, Jiong Zhang, Haoran Liu, et al.. (2022). CXCR3 antagonist AMG487 ameliorates experimental autoimmune prostatitis by diminishing Th1 cell differentiation and inhibiting macrophage M1 phenotypic activation. The Prostate. 82(13). 1223–1236. 11 indexed citations
10.
Li, Chun, Jie Zhu, Hexi Du, & Chang Yin Liang. (2022). Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence. Frontiers in Oncology. 12. 814912–814912. 4 indexed citations
11.
Chen, Jing, Ligang Zhang, Hexi Du, et al.. (2021). Melatonin attenuates prostatic inflammation and pelvic pain via Sirt1‐dependent inhibition of the NLRP3 inflammasome in an EAP mouse model. The Prostate. 81(15). 1179–1190. 20 indexed citations
12.
Liang, Li, Hexi Du, Jun Zhou, et al.. (2021). Application of Contrast-Enhanced Ultrasonography (CEUS) in the Assessment of Kidney Wound Recovery After Nephron-Sparing Surgery. Cancer Management and Research. Volume 13. 3925–3934.
13.
Du, Hexi, Yi Liu, Ligang Zhang, et al.. (2020). Abnormal gut microbiota composition is associated with experimental autoimmune prostatitis‐induced depressive‐like behaviors in mice. The Prostate. 80(9). 663–673. 21 indexed citations
14.
Yu, Zhifeng, et al.. (2020). Baicalin suppresses the cell cycle progression and proliferation of prostate cancer cells through the CDK6/FOXM1 axis. Molecular and Cellular Biochemistry. 469(1-2). 169–178. 25 indexed citations
15.
Chen, Jia, Jing Chen, Ligang Zhang, et al.. (2020). CaMK4‐dependent phosphorylation of Akt/mTOR underlies Th17 excessive activation in experimental autoimmune prostatitis. The FASEB Journal. 34(10). 14006–14023. 27 indexed citations
16.
Liang, Chang Yin, Li Zhang, Yi Liu, et al.. (2019). MicroRNA expression profile in chronic nonbacterial prostatitis revealed by next-generation small RNA sequencing. Asian Journal of Andrology. 21(4). 351–351. 14 indexed citations
17.
Du, Hexi, Xianguo Chen, Li Zhang, et al.. (2019). Experimental Autoimmune Prostatitis Induces Learning-Memory Impairment and Structural Neuroplastic Changes in Mice. Cellular and Molecular Neurobiology. 40(1). 99–111. 21 indexed citations
18.
Chen, Jing, Li Zhang, Ligang Zhang, et al.. (2019). The Hypermethylation of Foxp3 Promoter Impairs the Function of Treg Cells in EAP. Inflammation. 42(5). 1705–1718. 21 indexed citations
19.
Du, Hexi, Xianguo Chen, Li Zhang, et al.. (2019). <p>Microglial activation and neurobiological alterations in experimental autoimmune prostatitis-induced depressive-like behavior in mice</p>. Neuropsychiatric Disease and Treatment. Volume 15. 2231–2245. 34 indexed citations
20.
Huang, Meng, et al.. (2018). The association of HIF-1&alpha; expression with clinicopathological significance in prostate cancer: a meta-analysis. Cancer Management and Research. Volume 10. 2809–2816. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026